406 related articles for article (PubMed ID: 22967863)
1. Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction.
Lee H; Min K; Kim EK; Kim TI
Am J Ophthalmol; 2012 Dec; 154(6):949-957.e1. PubMed ID: 22967863
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.
Lee H; Chung B; Kim KS; Seo KY; Choi BJ; Kim TI
Am J Ophthalmol; 2014 Dec; 158(6):1172-1183.e1. PubMed ID: 25128594
[TBL] [Abstract][Full Text] [Related]
3. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.
Souchier M; Joffre C; Grégoire S; Bretillon L; Muselier A; Acar N; Beynat J; Bron A; D'Athis P; Creuzot-Garcher C
Br J Ophthalmol; 2008 Jun; 92(6):819-22. PubMed ID: 18511542
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers.
Ko JS; Seo Y; Chae MK; Jang SY; Yoon JS
Eye (Lond); 2018 Feb; 32(2):439-445. PubMed ID: 29052604
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
Prabhasawat P; Tesavibul N; Mahawong W
Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
[TBL] [Abstract][Full Text] [Related]
6. Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status.
Jung JW; Han SJ; Nam SM; Kim TI; Kim EK; Seo KY
Clin Exp Ophthalmol; 2016 Sep; 44(7):555-562. PubMed ID: 26989003
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of meibomian gland dysfunction.
Romero JM; Biser SA; Perry HD; Levinson DH; Doshi SJ; Terraciano A; Donnenfeld ED
Eye Contact Lens; 2004 Jan; 30(1):14-9. PubMed ID: 14722463
[TBL] [Abstract][Full Text] [Related]
8. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
9. The Level of Inflammatory Tear Cytokines is Elevated in Congenital Aniridia and Associated with Meibomian Gland Dysfunction.
Landsend ECS; Utheim ØA; Pedersen HR; Aass HCD; Lagali N; Dartt DA; Baraas RC; Utheim TP
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2197-2204. PubMed ID: 29801153
[TBL] [Abstract][Full Text] [Related]
10. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls.
Eom Y; Lee JS; Kang SY; Kim HM; Song JS
Am J Ophthalmol; 2013 Jun; 155(6):1104-1110.e2. PubMed ID: 23465270
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.
Pinna A; Piccinini P; Carta F
Cornea; 2007 Apr; 26(3):260-4. PubMed ID: 17413949
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: a randomized trial.
Satitpitakul V; Ratanawongphaibul K; Kasetsuwan N; Reinprayoon U
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1289-1294. PubMed ID: 31011823
[TBL] [Abstract][Full Text] [Related]
13. Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction.
Lee H; Kim M; Park SY; Kim EK; Seo KY; Kim TI
Clin Exp Optom; 2017 Nov; 100(6):598-602. PubMed ID: 28295626
[TBL] [Abstract][Full Text] [Related]
14. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease.
Macri A; Pflugfelder S
Arch Ophthalmol; 2000 Dec; 118(12):1632-8. PubMed ID: 11115257
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction.
Matsumoto Y; Dogru M; Goto E; Ishida R; Kojima T; Onguchi T; Yagi Y; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):644-50. PubMed ID: 17077654
[TBL] [Abstract][Full Text] [Related]
17. A standardized visual scale for evaluation of tear fluorescein clearance.
Macri A; Rolando M; Pflugfelder S
Ophthalmology; 2000 Jul; 107(7):1338-43. PubMed ID: 10889108
[TBL] [Abstract][Full Text] [Related]
18. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.
Greiner JV
Curr Eye Res; 2012 Apr; 37(4):272-8. PubMed ID: 22324772
[TBL] [Abstract][Full Text] [Related]
19. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).
Cuevas M; González-García MJ; Castellanos E; Quispaya R; Parra Pde L; Fernández I; Calonge M
Curr Eye Res; 2012 Oct; 37(10):855-63. PubMed ID: 22632103
[TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
